Craig Boerner

May 18, 2017

VUMC’s Barocas honored by Society of Urologic Oncology

Daniel Barocas, M.D., associate professor of Urologic Surgery, recently received the Society of Urologic Oncology’s (SUO) Young Investigator Award at the group’s 2017 annual meeting in Boston.

By Craig Boerner
May 11, 2017

Hepatitis C infections among pregnant women increasing

Hepatitis C infections among pregnant women nearly doubled from 2009-2014, likely a consequence of the country’s increasing opioid epidemic that is disproportionately affecting rural areas of states including Tennessee and West Virginia.

By Craig Boerner
March 30, 2017

Penson to chair urology association’s science, quality council

David Penson, M.D., MPH, Paul V. Hamilton, M.D., and Virginia E. Howd Professor of Urologic Oncology and chair of the Department of Urologic Surgery, has been selected to chair the American Urological Association (AUA) Science & Quality Council, according to an announcement from the AUA Board of Directors.

By Craig Boerner
March 23, 2017

Urology association honors Kaufman

Melissa Kaufman, M.D., Ph.D., associate professor of Urologic Surgery, received the 2017 Zimskind Award at the Society of Urodynamics, Female Pelvic Medicine, and Urogenital Reconstruction (SUFU) Winter Meeting in Scottsdale, Arizona.

By Craig Boerner
March 21, 2017

Study shows active surveillance preserves quality of life for prostate cancer patients

Faced with the negative quality-of-life effects from surgery and radiation treatments for prostate cancer, low risk patients may instead want to consider active surveillance with their physician, according to a study released Tuesday by the Journal of the American Medical Association (JAMA).

By Craig Boerner
Overweight or obese family in the park
March 16, 2017

VUMC joins cutting-edge obesity research network

Vanderbilt University Medical Center (VUMC) is one of four centers receiving a $15 million, four-year research award from the American Heart Association (AHA) to provide cutting-edge research on obesity as part of its sixth Strategically Focused Research Network (SFRN).

By Craig Boerner
February 8, 2017

Social risk factors influence outcomes, Medicare payment

Social risk factors including income, education and ethnic background influence health outcomes and should be taken into account in Medicare payment models, according to a New England Journal of Medicine “Perspective” titled “Social Risk Factors and Equity in Medicare Payment.”
By Craig Boerner
February 2, 2017

Study finds smaller insurers earning profits in new market

The researchers examine whether the financial struggles of some major insurers under the Affordable Care Act reflect a policy failure or a mismatch of these firms’ capabilities and strategies to a newly created market.
By Craig Boerner
December 27, 2016

Investigational new drug for Alzheimer’s scheduled for first study in humans

Vanderbilt University scientists have received notification from the U.S. Food and Drug Administration that testing in humans may proceed for an investigational new drug for Alzheimer's disease after more than 10 years of research by scientists at Vanderbilt University and Vanderbilt University Medical Center.
By Craig Boerner
December 15, 2016

Babies born with opioid withdrawal disproportionately increasing in rural areas

An increasing number of newborns are being born with drug withdrawal symptoms from opioids in rural areas of the United States as compared to births in urban areas, according to a JAMA Pediatrics study.
By Craig Boerner
November 10, 2016

Study tracks diabetes management via text messaging

The REACH study is offering Vanderbilt University Medical Center (VUMC) primary care patients with type 2 diabetes an opportunity to more easily track medication adherence, monitor A1C results, and make healthy lifestyle choices via text messaging.
By Craig Boerner
September 22, 2016

New prostate cancer therapy investigated at VUMC

Vanderbilt University Medical Center is the world’s first site to treat a patient in the TULSA-PRO Ablation Clinical Trial (TACT), which employs an emerging therapy that uses MRI guidance and robotically driven therapeutic ultrasound to obtain precise prostate cancer tissue ablation.
By Craig Boerner